Pharm Exec’s 13th Annual Press Audit audit reveals a tonal undercurrent in sync with an industry unable to escape the glare of scrutiny.
George P. Sillup, Stephen J. Porth, Cynthia Slater
Advertisement
George P. Sillup, Ph.D., M.S., is Arrupe Fellow & Associate Professor, and Stephen J. Porth, Ph.D., Associate Dean is Arrupe Fellow & Professor, both at Saint Joseph's University (SJU), Philadelphia, PA. Cynthia Slater is SJU’s Business Reference Librarian.
Articles by George P. Sillup, Stephen J. Porth, Cynthia Slater
If it feels like the media’s scrutiny of pharma has intensified recently, there's a reason-it has, as the results of our 13th Annual Press Audit indicate.
Advertisement
Latest Updated Articles
Pharm Execs 13th Annual Press AuditPublished: July 6th 2017 | Updated:
News Spotlight: PharmaPublished: August 9th 2017 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Excellergy Announces Launch with $70 Million Series A Funding Aiming to Advance Pipeline of Trifunctional Effector Cell Response Inhibitors
2
Pharma Companies Shift Towards Direct-To-Consumer Sales in US Amidst Tariff and Pricing Turmoil
3
How are the Drug Pricing Negotiations Impacting Pharma's Relationship with DC?
4
The Most-Favored-Nation Policy: Outlook and Implications Beyond U.S.
5
